1 – 10 of 330
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
(
- Contribution to journal › Article
-
Mark
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
2023) In Journal of Translational Medicine(
- Contribution to journal › Article
-
Mark
Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
(
- Contribution to journal › Article
-
Mark
Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
(
- Contribution to journal › Article
-
Mark
Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study
(
- Contribution to journal › Article
-
Mark
Obesity-associated changes in molecular biology of primary breast cancer
(
- Contribution to journal › Article
-
Mark
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
(
- Contribution to journal › Article
- 2022
-
Mark
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores
(
- Contribution to journal › Article
-
Mark
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants
(
- Contribution to journal › Article
-
Mark
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
(
- Contribution to journal › Article